Sunday 11 October 2026 Export all EQ data to Excel Powerpack

Equillium, Inc.

EQ Healthcare Biotechnology

Equillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023. In the quarter to June 2026, revenue fell 52.3%, EPS grew 75.0% and free cash flow fell 38.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.

1.41 0.03 −2.08%
Market cap
$91.3M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
3/9
Altman Z
−6.75
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Piotroski F-Score
— 3 — — — — — — —
P/E ratio
— 0.00 0.00 0.00 — — — — —
Altman Z-Score
— (6.75) (4.33) (4.34) — — — — —
P/S ratio
— 0.65 0.70 0.00 — — — — —
P/FCF ratio
— 0.00 0.00 0.00 — — — — —
Altman Z″-Score (non-manufacturers)
— (19.02) (10.24) (8.03) — — — — —
Beneish M-Score
— — (0.88) — — — — — —
P/Operating CF
— (8.04) (4.48) 1.29 — — — — —
P/B ratio
— 1.39 1.12 1.12 — — — — —
EV/Sales
— 0.28 (0.22) 0.00 — — — — —
EV/EBITDA
— 0.00 0.53 0.34 — — — — —
EV/FCF
— (0.60) 0.36 2.92 — — — — —
Current Ratio
10.58 3.93 1.79 2.40 9.35 11.76 14.28 33.09 12.57
Net Debt/EBITDA
1.29 2.54 2.70 1.01 1.90 2.48 1.61 7.66 (0.56)
Debt/Equity
0.00 0.00 0.00 0.28 0.15 0.14 0.23 0.00 (3.58)
ROE
(93.99%) (38.75%) (48.92%) (126.83%) (57.28%) (53.38%) (47.95%) (42.28%) (7.22%)
ROA
(77.92%) (21.19%) (20.68%) (76.21%) (45.72%) (42.30%) (41.73%) (35.66%) (6.09%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(79.23%) (42.72%) (60.36%) (138.46%) (52.28%) (38.14%) (49.57%) (20.34%) (34.36%)
Average Days of Receivables
— 0.00 37.78 65.73 — — — — —
Earnings Yield
— (30.69%) (53.42%) (179.25%) — — — — —
Free Cash Flow Yield
— (72.07%) (86.13%) (25.21%) — — — — —
Free Cash Flow per Share
(0.40) (0.54) (0.63) (0.27) (1.12) (1.22) (1.32) (0.62) (0.07)
Book value per Share
0.50 0.54 0.65 0.95 2.31 3.43 2.41 5.33 (0.22)
Free Cash Flow
(22.78) (19.11) (21.83) (9.01) (32.14) (24.83) (23.02) (7.56) (0.66)
EV/EBIT
— 0.00 0.55 0.42 — — — — —
Other line items

Show all line items

Columns are period end dates